World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
62
Citations
14200
World Ranking
2873
National Ranking
254

Kholoud Porter publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Kholoud Porter sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 213 publications — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Kholoud Porter D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Kholoud Porter sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 62 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Kholoud Porter is affiliated with University College London in the United Kingdom. Their research primarily focuses on the fields of Medicine and Immunology and Microbiology, with a significant emphasis on Infectious Diseases and Virology. The scientist has contributed extensively to studies concerning HIV/AIDS and related health issues.

The main topics addressed in their work include:

  • HIV/AIDS Research and Interventions
  • HIV Research and Treatment
  • HIV, Drug Use, Sexual Risk
  • HIV-related health complications and treatments
  • HIV/AIDS drug development and treatment
  • Sex work and related issues
  • Dermatological diseases and infestations

Their recent publications demonstrate involvement in research spanning HIV epidemiology, treatment initiation effects, and disease control strategies. Selected papers include:

  • A highly virulent variant of HIV-1 circulating in the Netherlands, 2022, Science
  • Human Immunodeficiency Virus Continuum of Care in 11 European Union Countries at the End of 2016 Overall and by Key Population: Have We Made Progress?, 2020, Clinical Infectious Diseases
  • Mass drug administration for endemic scabies: a systematic review, 2021, Tropical Diseases Travel Medicine and Vaccines
  • Changes in bodyweight after initiating antiretroviral therapy close to HIV-1 seroconversion: an international cohort collaboration, 2024, The Lancet HIV
  • HIV-phyloTSI: Subtype-independent estimation of time since HIV-1 infection for cross-sectional measures of population incidence using deep sequence data, 2022, bioRxiv (Cold Spring Harbor Laboratory)

Porter frequently collaborates with a set of co-authors well-known in HIV research and epidemiology, including:

  • Laurence Meyer
  • Giota Touloumi
  • Peter Reiss
  • Caroline Sabin
  • Jacques Fellay

Their publications are frequently found in these venues:

  • UNC Libraries
  • The Lancet HIV
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Science
  • Clinical Infectious Diseases

The scientist's work spans interdisciplinary approaches within infectious diseases, combining epidemiological analysis, clinical treatment evaluation, and molecular virology. Their research contributes to understanding HIV infection dynamics, treatment efficacy, and public health interventions in diverse populations.

Best Publications

  • Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy

    Margaret T. May;Mark Gompels;Valerie Delpech;Kholoud Porter

  • Changes in the risk of death after HIV seroconversion compared with mortality in the general population.

    Krishnan Bhaskaran;Osamah Hamouda;Mette Sannes;Faroudy Boufassa

  • Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis

    A Babiker;S Darby;D De Angelis;D Kwart

  • Determinants of survival following HIV-1 seroconversion after the introduction of HAART.

    Kholoud Porter;Abdel Babiker;Krishnan Bhaskaran;Janet Darbyshire

  • Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study

    Linda Wittkop;Huldrych F Günthard;Frank de Wolf;David Dunn

  • Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study

    Margaret T May;Mark Gompels;Valerie Delpech;Kholoud Porter

  • Beyond viral suppression of HIV – the new quality of life frontier

    Jeffrey V. Lazarus;Jeffrey V. Lazarus;Kelly Safreed-Harmon;Simon E. Barton;Dominique Costagliola

  • Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy.

    Benoît Marin;Rodolphe Thiébaut;Heiner C. Bucher;Virginie Rondeau

  • Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion.

    Colette Smit;Ronald Geskus;Sarah Walker;Caroline Sabin

  • Short-course antiretroviral therapy in primary HIV infection.

    S Fidler;K Porter;F Ewings

  • Response to combination antiretroviral therapy: variation by age

    Sabin Ca;Smith Cj;d'Arminio Monforte A

  • Time From Human Immunodeficiency Virus Seroconversion to Reaching CD4+ Cell Count Thresholds <200, <350, and <500 Cells/mm3: Assessment of Need Following Changes in Treatment Guidelines

    Sara Lodi;Andrew Phillips;Giota Touloumi;Ronald Geskus

  • Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy.

    Krishnan Bhaskaran;Cristina Mussini;Andrea Antinori;Ann Sarah Walker

  • Time trends in primary resistance to HIV drugs in the United Kingdom: multicentre observational study.

    Patricia Cane;Ian Chrystie;David Dunn;Barry Evans

  • Analysis of prevalence of HIV-1 drug resistance in primary infections in the United Kingdom

    Kholoud Porter;Deenan Pillay;Patricia Cane;Gill Dean

  • Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practice.

    A.N. Phillips;D. Dunn;C. Sabin;A. Pozniak

  • Long-term Mortality in HIV-Positive Individuals Virally Suppressed for > 3 Years With Incomplete CD4 Recovery

    Frederik N. Engsig;Robert Zangerle;Olga Katsarou;Francois Dabis

  • The hepatitis C epidemic among HIV-positive MSM : incidence estimates from 1990 to 2007

    Jannie J. van der Helm;Maria Prins;Julia del Amo;Heiner C. Bucher

  • Kaposi Sarcoma Incidence and Survival Among HIV-Infected Homosexual Men After HIV Seroconversion

    Sara Lodi;Marguerite Guiguet;Dominique Costagliola;Martin Fisher

  • Prospective study of clinical, laboratory, and ancillary staff with accidental exposures to blood or body fluids from patients infected with HIV.

    M McEvoy;K Porter;P Mortimer;N Simmons

Frequent Co-Authors

Caroline Sabin
Caroline Sabin University College London
Andrew N. Phillips
Andrew N. Phillips University College London
Sarah Fidler
Sarah Fidler Imperial College London
Martin Fisher
Martin Fisher University of Sussex
Richard Gilson
Richard Gilson University College London
Deenan Pillay
Deenan Pillay University College London
Clifford Leen
Clifford Leen Western General Hospital
Chloe Orkin
Chloe Orkin Queen Mary University of London
Maria Prins
Maria Prins University of Amsterdam
Laurence Meyer
Laurence Meyer University of Paris-Saclay

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to various interdisciplinary career paths that align well with health sciences and data management. For those interested in combining clinical expertise with patient care, becoming a functional medicine nurse practitioner salary reflects the growing demand for practitioners who approach health holistically.

On the administrative and coding side, obtaining a certified professional coder certification can be an excellent option. This certification prepares professionals to manage medical codes efficiently, bridging clinical knowledge and healthcare billing procedures.

For those interested in organizational leadership within healthcare, a health-centric degree such as a bachelor’s in health information management offers promising prospects, with salaries outlined in the health information management bachelor degree salary research. This field involves managing patient data, ensuring compliance, and improving healthcare delivery systems.

To pursue this path online, prospective students can explore cahiim accredited health information management degree online programs. These accredited courses ensure quality education and prepare graduates for certification exams, enhancing career readiness in the evolving healthcare landscape.

Best Scientists Citing Kholoud Porter

Trending Scientists

Recently Published Articles